Evolent Health Inc (NYSE: EVH) has reported a loss for its fourth fiscal quarter (ending December 31) of $-0.27 versus a loss $-0.36 for the same period a year ago — a decline of -25%. For the latest four quarters through December 31, E.P.S. were $-0.81 versus $-1.28 for the same period a year ago — a decline of -37%.
Recent Price Action
Evolent Health Inc (NYSE: EVH) stock increased 1.8% on 2/20/25. The shares closed at $10.71. Moreover, trading volume in this advance was above average at 124% of normal. The stock has been extremely weak relative to the market over the last nine months but has risen 8.6% during the last week.
Current PriceTarget Research Rating
Evolent Health has a current Value Trend Rating of D (Negative). The Value Trend Rating reflects very contradictory signals from PTR’s two proprietary measures of a stock’s attractiveness. Evolent Health has a slightly positive Appreciation Score of 69 but a very low Power Rating of 4, producing the Negative Value Trend Rating.
Rating Review
In light of this new information we are reviewing our current Overall Rating of D. This review will be completed in the next several days.
Be the first to comment